Terms: = Lymphoma AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Treatment
29 results:
1. Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea.
Yun J; Song H; Kim SM; Kim S; Kwon SR; Lee YE; Jeong D; Park JH; Kwon S; Yun H; Lee DS
Hum Genomics; 2023 Feb; 17(1):13. PubMed ID: 36814285
[TBL] [Abstract] [Full Text] [Related]
2. Diagnostic and therapeutic approach to children with Nijmegen breakage syndrome in relation to development of lymphoid malignancies.
Filipiuk A; Kozakiewicz A; Kośmider K; Lejman M; Zawitkowska J
Ann Agric Environ Med; 2022 Jun; 29(2):207-214. PubMed ID: 35767752
[TBL] [Abstract] [Full Text] [Related]
3. Geographical Distribution, Incidence, Malignancies, and Outcome of 136 Eastern Slavic Patients With Nijmegen Breakage Syndrome and
Sharapova SO; Pashchenko OE; Bondarenko AV; Vakhlyarskaya SS; Prokofjeva T; Fedorova AS; Savchak I; Mareika Y; Valiev TT; Popa A; Tuzankina IA; Vlasova EV; Sakovich IS; Polyakova EA; Rumiantseva NV; Naumchik IV; Kulyova SA; Aleshkevich SN; Golovataya EI; Minakovskaya NV; Belevtsev MV; Latysheva EA; Latysheva TV; Beznoshchenko AG; Akopyan H; Makukh H; Kozlova O; Varabyou DS; Ballow M; Ong MS; Walter JE; Kondratenko IV; Kostyuchenko LV; Aleinikova OV
Front Immunol; 2020; 11():602482. PubMed ID: 33488600
[TBL] [Abstract] [Full Text] [Related]
4. [Ceritinib in the treatment of an adult patient with advanced neuroblastoma positive to the somatic activating mutation of ALK F1174L.].
Soto Parra HJ; Noto L; Aiello MM
Recenti Prog Med; 2020 Dec; 111(12):58e-62e. PubMed ID: 33362184
[TBL] [Abstract] [Full Text] [Related]
5. Inhibition of SKP2 Activity Impaired ATM-Mediated DNA Repair and Enhanced Sensitivity of Cisplatin-Resistant Mantle Cell lymphoma Cells.
Yan W; Yang Y; Yang W
Cancer Biother Radiopharm; 2019 Sep; 34(7):451-458. PubMed ID: 31025879
[No Abstract] [Full Text] [Related]
6. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
Urtishak KA; Wang LS; Culjkovic-Kraljacic B; Davenport JW; Porazzi P; Vincent TL; Teachey DT; Tasian SK; Moore JS; Seif AE; Jin S; Barrett JS; Robinson BW; Chen IL; Harvey RC; Carroll MP; Carroll AJ; Heerema NA; Devidas M; Dreyer ZE; Hilden JM; Hunger SP; Willman CL; Borden KLB; Felix CA
Oncogene; 2019 Mar; 38(13):2241-2262. PubMed ID: 30478448
[TBL] [Abstract] [Full Text] [Related]
7. Annual Facility treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome.
Kann BH; Park HS; Yeboa DN; Aneja S; Girardi M; Foss FM; Roberts KB; Wilson LD
Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):520-526.e2. PubMed ID: 28655598
[TBL] [Abstract] [Full Text] [Related]
8. Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity.
Charbonnel C; Convers-Domart R; Rigaudeau S; Taksin AL; Baron N; Lambert J; Ghez S; Georges JL; Farhat H; Lambert J; Rousselot P; Livarek B
Eur Heart J Cardiovasc Imaging; 2017 Apr; 18(4):392-401. PubMed ID: 28064155
[TBL] [Abstract] [Full Text] [Related]
9. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
[TBL] [Abstract] [Full Text] [Related]
10. Clinical course and therapeutic implications for lymphoid malignancies in Nijmegen breakage syndrome.
Pastorczak A; Szczepanski T; Mlynarski W;
Eur J Med Genet; 2016 Mar; 59(3):126-32. PubMed ID: 26826318
[TBL] [Abstract] [Full Text] [Related]
11. Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and treatment Options - a Retrospective Analysis.
Wolska-Kuśnierz B; Gregorek H; Chrzanowska K; Piątosa B; Pietrucha B; Heropolitańska-Pliszka E; Pac M; Klaudel-Dreszler M; Kostyuchenko L; Pasic S; Marodi L; Belohradsky BH; Čižnár P; Shcherbina A; Kilic SS; Baumann U; Seidel MG; Gennery AR; Syczewska M; Mikołuć B; Kałwak K; Styczyński J; Pieczonka A; Drabko K; Wakulińska A; Gathmann B; Albert MH; Skarżyńska U; Bernatowska E;
J Clin Immunol; 2015 Aug; 35(6):538-49. PubMed ID: 26271390
[TBL] [Abstract] [Full Text] [Related]
12. EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
Nalluri S; Peirce SK; Tanos R; Abdella HA; Karmali D; Hogarty MD; Goldsmith KC
Cancer Biol Ther; 2015; 16(2):276-86. PubMed ID: 25756510
[TBL] [Abstract] [Full Text] [Related]
13. Vitreous evaluation: a diagnostic challenge.
Mehta M; Rasheed RA; Duker J; Reichel E; Feinberg E; Husain D; Foster CS; Laver NV
Ophthalmology; 2015 Mar; 122(3):531-7. PubMed ID: 25439597
[TBL] [Abstract] [Full Text] [Related]
14. Genetic predisposition to radiation-related cancer and potential implications for risk assessment.
Sigurdson AJ; Stram DO
Ann ICRP; 2012; 41(3-4):108-16. PubMed ID: 23089009
[TBL] [Abstract] [Full Text] [Related]
15. DNA repair polymorphisms influence the risk of second neoplasm after treatment of childhood acute lymphoblastic leukemia.
Erčulj N; Faganel Kotnik B; Debeljak M; Jazbec J; Dolžan V
J Cancer Res Clin Oncol; 2012 Nov; 138(11):1919-30. PubMed ID: 22752646
[TBL] [Abstract] [Full Text] [Related]
16. Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors.
Kwon MJ; Choi YL; Sung KW; Kang SY; Park SM; Choi SY; Kim JS; Suh YL
Pathol Res Pract; 2011 Oct; 207(10):634-9. PubMed ID: 21940108
[TBL] [Abstract] [Full Text] [Related]
17. Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey.
Bienemann K; Burkhardt B; Modlich S; Meyer U; Möricke A; Bienemann K; Mauz-Körholz C; Escherich G; Zimmermann M; Körholz D; Janka-Schaub G; Schrappe M; Reiter A; Borkhardt A
Br J Haematol; 2011 Nov; 155(4):468-76. PubMed ID: 21923652
[TBL] [Abstract] [Full Text] [Related]
18. Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions.
Rubio R; Serrano O; Carmena J; Asensi V; Echevarría S; Flores J; Ribera E; Zarraga M; Ocampo A; de la Fuente B; Sepúlveda MA; Mariño AI; Minguez C; Vicent R; Cartón JA; Moyano B; Esteban H; Mahillo B; Serrano L; González-García J;
HIV Med; 2010 Oct; 11(9):545-53. PubMed ID: 20345884
[TBL] [Abstract] [Full Text] [Related]
19. Successful treatment of hodgkin lymphoma in nijmegen breakage syndrome.
Jovanovic A; Minic P; Scekic-Guc M; Djuricic S; Cirkovic S; Weemaes C; Pasic S
J Pediatr Hematol Oncol; 2009 Jan; 31(1):49-52. PubMed ID: 19125088
[TBL] [Abstract] [Full Text] [Related]
20. Ifosfamide or trofosfamide in patients with intraocular lymphoma.
Jahnke K; Thiel E; Bechrakis NE; Willerding G; Kraemer DF; Fischer L; Korfel A
J Neurooncol; 2009 Jun; 93(2):213-7. PubMed ID: 19099202
[TBL] [Abstract] [Full Text] [Related]
[Next]